Gunting, Baby Girl P.
HRN: 21-89-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/15/2022
09/22/2022
IV
28mg
Q6hours
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes